Issue 6/2018
Content (19 Articles)
Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia
Daniel G. Guy, Geoffrey L. Uy
Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies
Imo J. Akpan, Afaf E. G. Osman, Michael W. Drazer, Lucy A. Godley
Chronic Myeloid Leukemia: Beyond BCR-ABL1
Ting Zhou, L. Jeffrey Medeiros, Shimin Hu
Recent Updates on Chronic Myelomonocytic Leukemia
Sanam Loghavi, Joseph D. Khoury
Minimal/Measurable Residual Disease Detection in Acute Leukemias by Multiparameter Flow Cytometry
Franklin Fuda, Weina Chen
Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria
Maria Sanz-De Pedro, Wei Wang, Rashmi Kanagal-Shamanna, Joseph D. Khoury
Blastic Plasmacytoid Dendritic Cell Neoplasm
Joseph D. Khoury
Hematopoietic Stem Cell Transplantation in the Era of Engineered Cell Therapy
Jacob S. Appelbaum, Filippo Milano
Novel Immunotherapies for T Cell Lymphoma and Leukemia
Paola Ghione, Alison J. Moskowitz, Nadia E. K. De Paola, Steven M. Horwitz, Marco Ruella
Leveraging Hypomethylating Agents for Better MDS Therapy
Terrence J. Bradley, Justin M. Watts, Ronan T. Swords
Breast Implant-Associated Anaplastic Large Cell Lymphoma
P. Rastogi, A. K. Deva, H. Miles Prince
Targeted Therapies in CLL: Monotherapy Versus Combination Approaches
Maliha Khan, Tanya Siddiqi
Anti-CD19 Chimeric Antigen Receptor T Cell Therapies: Harnessing the Power of the Immune System to Fight Diffuse Large B Cell Lymphoma
Robert Havard, Deborah M. Stephens
Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Bei Hu, Ryan Jacobs, Nilanjan Ghosh
Combining Biology and Chemistry for a New Take on Chemotherapy: Antibody-Drug Conjugates in Hematologic Malignancies
Helen Ma, Ahmed Sawas
Online and Social Media Resources for Patients with MDS
Nour Abuhadra, Aziz Nazha
Social Media and Hematopoietic Cell Transplantation: a Review of Online Resources and Communities
Sagar S. Patel, Navneet S. Majhail
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN—Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community
Naveen Pemmaraju, Audun Utengen, Vikas Gupta, Michael A. Thompson, Andrew A. Lane
Leukemic Transformation of Myeloproliferative Neoplasms: Therapeutic and Genomic Considerations
Bing Li, John O. Mascarenhas, Raajit K. Rampal